A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache

Journal of Neurology Neurosurgery and Psychiatry

Volumn 61, Issue 3, 1996, Pages 285-290

  Bendtsen, Lars ^a   Jensen, Rigmor ^a   Olesen, Jes ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Antidepressants; Pain; Tension type headache

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TENSION; XEROSTOMIA;

EID: 0029841944     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.61.3.285     Document Type: Article

References (37)

1. Rasmussen BK, Jensen R, Olesen J. Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J Epidemiol Community Health 1992;46:443-6.
2. Couch JR, Micieli G. Prophylactic Pharmacotherapy. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches. New York: Raven Press 1993:537-42.
3. Lance JW, Curran DA. Treatment of chronic tension headache. Lancet 1964;i:1236-9.
4. Diamond S, Baltes BJ. Chronic tension headache - treated with amitriptyline - a double-blind study. Headache 1971;11:110-6.
5. Pfaffenrath V, Diener HC, Isler H, et al. Efficacy and tolerability of amitriptylinoxide in the treatment of chronic tension-type headache: a multi-centre controlled study. Cephalalgia 1994;14:149-55.
6. Göbel H, Hamouz V, Hansen C, et al. Chronic tension-type headache: amitriptyline reduces clinical headache-duration and experimental pain sensitivity but does not alter pericranial muscle activity readings. Pain 1994; 59:241-9.
7. Botney M, Fields HL. Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system. Ann Neurol 1983;13:160-4.
8. Tollison CD, Kriegel ML. Selected tricyclic antidepressants in the management of chronic benign pain. South Med J 1988;81:562-4.
9. Tura B, Tura SM. The analgesic effect of tricyclic antidepressants. Brain Res 1990;518:19-22.
10. Sacerdote P, Brini A, Mantegazza P, Panerai AE. A role for serotonin and beta-endorphin in the analgesia induced by some tricyclic antidepressant drugs. Pharmacol Biochem Behav 1987;26:153-8.
11. Bech P, Cialdella P. Citalopram in depression - metaanalysis of intended and unintended effects. Int Clin Psychopharmacol 1992;6:45-54.
12. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988:8 suppl 7, 1-96.
13. Russell MB, Rasmussen BK, Brennum J, Iversen HK, Jensen RA, Olesen J. Presentation of a new instrument: the diagnostic headache diary. Cephalalgia 1992;12: 369-74.
14. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
15. Altman DG. Practical statistics for medical research. London: Chapman and Hall, 1991.
16. Magni G. The use of antidepressants in the treatment of chronic pain. A review of the current evidence. Drugs 1991;42:730-48.
17. Johansson F, von Knorring L. A double-blind controlled study of serotonin uptake inhibitor (Zimelidine) versus placebo in chronic pain patients. Pain 1979;7:69-78.
18. Sindrup SH, Gram LF, Brosen K, Eshoj C, Mogensen EF. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990;42:135-44.
19. Sindrup SH, Bjerre U, Dejgaard A, Brosen K, Aaes Jorgensen T, Gram LF. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 1992;52: 547-52.
20. Saper JR, Silberstein SD, Lake AE, Winters ME. Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache 1994;34:497-502.
21. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992; 326:1250-6.
22. Norregaard J, Volkmann H, Danneskiold-Samsoe B. A randomized controlled trial of citalopram in the treatment of fibromyalgia. Pain 1995;61:445-9.
23. Tfelt-Hansen P, Olesen J. Methodological aspects of drug trials in migraine. Neuroepidemiology 1985;4: 204-26.
24. International Headache Society Committee on Clinical Trials. Guidelines for trials of drug treatments in tension-type headache. Cephalalgia 1995;15:165-79.
25. Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990;300:230-5.
26. Sharav Y, Singer E, Schmidt E, Dionne RA, Dubner R. The analgesic effect of amitriptyline on chronic facial pain. Pain 1987;31:199-209.
27. Panerai AE, Monza G, Movilia P, Bianchi M, Francucci BM, Tiengo M. A randomized, within-patient, cross-over, placebo-controlled trial on the efficacy and tolerability of the tricyclic antidepressants chlorimipramine and nortriptyline in central pain. Acta Neurol Scand 1990;82: 34-8.
28. Egbunike IG, Chaffee BJ. Antidepressants in the management of chronic pain syndromes. Pharmacotherapy 1990; 10:262-70.
29. Onghena P, Van Houdenhove B. Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain 1992;49:205-19.
30. Ardid D, Marty H, Fialip J, Privat AM, Eschalier A, Lavarenne J. Comparative effects of different uptake inhibitor antidepressants in two pain tests in mice. Fundam Clin Pharmacol 1992;6:75-82.
31. Watson CP, Evans RJ. A comparative trial of amitriptyline and zimelidine in post-herpetic neuralgia. Pain 1985;23: 387-94.
32. Hyttel J. Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171. Psychopharmacology 1977;51:225-33.
33. Taiwo YO, Fabian A, Pazoles CJ, Fields HL. Potentiation of morphine antinociception by monoamine reuptake inhibitors in the rat spinal cord. Pain 1985;21:329-37.
34. Hyttel J. Citalopram - pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiatry 1982;6: 277-95.
35. U'Prichard DC, Greenberg DA, Sheeman PP, Snyder SH. Tricyclic antidepressants: therapeutic properties and affinity for alpha-noradrenergic receptor binding sites in the brain. Science 1978;199:197-9.
36. Sindrup SH, Gram LF, Skjold T, Grodum E, Brosen K, Beck Nielsen H. Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study. Br J Clin Pharmacol 1990;30:683-91.
37. Glaum SR, Proudfit HK, Anderson EG. Reversal of the antinociceptive effects of intrathecally administered serotonin in the rat by a selective 5-HT-3 receptor antagonist. Neurosci Lett 1988;95:313-7.